Sarcopenia
Conditions
Interventions
control group:Comparison therapy paste taken with warm water + routine care + aerobic exercise (such as Baduanjin)
intervention group:Shenqi Paste taken with warm water + routine care + Aerobic exercise (Baduanjin, etc.)
Sponsors
Zhejiang Chinese Medical University
Eligibility
Sex/Gender
All
Age
60 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1) Diagnostic criteria for diagnosing sarcopenia; 2) Age range is 60-85 years old; 3) Those who meet the traditional Chinese medicine diagnosis of spleen and kidney deficiency type; 4) Voluntarily participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1) Metal devices or electronic medical instruments implanted in the body such as pacemakers are prohibited from using bioelectrical impedance Patients with severe abnormalities in physical functions such as heart liver and hematopoietic system; 3) Individuals with mental and emotional disorders (such as schizophrenia depression anxiety etc.) who are unable to cooperate; 4) Combining malignant tumors severe infections severe gastrointestinal bleeding active pulmonary tuberculosis and other diseases that affect nutritional status; 5) Physical disability unwillingness to participate in research or inability to complete follow-up; 6) For patients with poor treatment compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skeletal muscle strength; | — |
Secondary
| Measure | Time frame |
|---|---|
| C-reactive protein;Atrogin-1;Interleukin-6;Fasting insulin;myogenic differentiation antigen;Fasting blood glucose;Glycosylated hemoglobin;Activity of Daily Living;Skeletal muscle mass;Irisin;Advanced Glycation Endproducts;Nicotinamide adenine dinucleotide phosphate;5 sit up tests;FRAIL Scal;Simplified Depression GDS Scale;Muscle RING finer-1;Sarcopenia Assessment Tool for Clinical Frailty;Mini-Cog ;Myosin heavy chain;Interleukin-1ß;insulin growth factor;Pittsburgh Sleep Quality Index Scale;Tumor necrosis factor-a;Myostatin;International Physical Activity Questionnaire;Security monitoring indicators;Reactive oxygen species;Quantitative grading and scoring of traditional Chinese medicine syndromes;Superoxide dismutase;Fasting c-peptide;Short Form Health Survey 36;Malondialdehyde;Calf circumference;mini-nutritional assessment;Interleukin-15;Receptor of Advanced Glycation Endproducts; | — |
Countries
China
Contacts
Public ContactQiuhua Sun
Zhejiang Chinese Medical University
Outcome results
None listed